CryoCath partners Endocare on heart cryoablation
This article was originally published in Clinica
Executive Summary
CryoCath Technologies has signed a five-year marketing agreement with US-based Endocare. The deal gives CryoCath exclusive rights to market a line of surgical probe systems which the two firms will jointly develop for treatment of cardiac arrhythmias, particularly atrial fibrillation (AF).